Amarin Corp Plc (AMRN)

[jessellivermore]

BC..

George Soros, Ken Fisher, and most major market players explain how no one can predict the market with certainty, because we are always making decisions based on incomplete information and our personal involvement in the outcome creates bias. Fisher says the market usually moves in the direction that disappoints the greatest number of players.

I am not certain the recent rise seemingly created by a single fund is sustainable. What we do not know is what went into the funds decision. @twi (dancing) points out T. Lynch has a history with Amarin. The history is old history at this point relating to using a diazepam as a nasal spray to treat seizures. Very little to do with EPA. Is Lynch friends with Amarin principals? Is he just a shrewd shopper who saw an amazing bargain at 80 cents?

The "strange" occurrence of this purchase juxtaposed on the surprising decision on the part of the company not to complete the FDA SPA appeals process raises the possibility the FDA may be planning a pleasant surprise for the company. This is merely a conjecture on my part, and not a prediction. IMO the decision to drop the FDA appeals was not based on financial considerations, Amarin is already "lawyered up". By this time they should have the appeal routine, "down pat"..

What I worry about is biotechs are event driven and no news almost always means the PPS drifting lower. So unless we get more news, or StonePine fires another barrel the price may be heading back down.

":>) JL